{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:01:32Z","timestamp":1790262092538,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bacterial therapeutics hold great promise for cancer treatment by targeting oxygen-poor tumor regions and complementing existing therapies. However, current approaches often struggle with safety concerns and complex engineering. Developing a safe, effective delivery platform relying entirely on natural bacterial biosynthesis remains a challenge. Here we show that attenuated\n                    <jats:italic>Serratia marcescens<\/jats:italic>\n                    serves as a powerful biohybrid platform for cancer therapy by leveraging its natural biosynthesis of prodigiosin, a photosensitive pigment. We engineer\n                    <jats:italic>S. marcescens<\/jats:italic>\n                    to yield high prodigiosin levels, which exhibit strong intrinsic anti-cancer activity and near-infrared photosensitivity. In female mouse models of melanoma and colorectal cancer, this platform triggers robust systemic immune responses, including enhanced T cell recruitment and long-term memory against tumor recurrence. Furthermore, the bacteria induces tumor cell death via mitophagy, while photothermal properties of prodigiosin enables rapid, light-controlled bacterial clearance post-treatment. These findings establish\n                    <jats:italic>S. marcescens<\/jats:italic>\n                    as a versatile, self-regulating biosynthetic platform for precise and safe cancer immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-70949-4","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:36:10Z","timestamp":1775579770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A live biohybrid bacterial therapy based on engineered Serratia marcescens"],"prefix":"10.1038","volume":"17","author":[{"given":"Lihao","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haomiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-8077","authenticated-orcid":false,"given":"Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-5699","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-0527","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"70949_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1126\/science.add9667","volume":"378","author":"CR Gurbatri","year":"2022","unstructured":"Gurbatri, C. R., Arpaia, N. & Danino, T. Engineering bacteria as interactive cancer therapies. Science 378, 858\u2013864 (2022).","journal-title":"Science"},{"key":"70949_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","volume":"635","author":"A Redenti","year":"2024","unstructured":"Redenti, A. et al. Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature 635, 453\u2013461 (2024).","journal-title":"Nature"},{"key":"70949_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.apsb.2022.09.015","volume":"13","author":"Z Feng","year":"2023","unstructured":"Feng, Z. et al. Recent advances in bacterial therapeutics based on sense and response. Acta Pharm. Sin. B 13, 1014\u20131027 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"70949_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41579-020-0420-1","volume":"19","author":"JMV Makabenta","year":"2021","unstructured":"Makabenta, J. M. V. et al. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat. Rev. Microbiol 19, 23\u201336 (2021).","journal-title":"Nat. Rev. Microbiol"},{"key":"70949_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41551-021-00834-6","volume":"6","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria. Nat. Biomed. Eng. 6, 44 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"70949_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-024-01973-3","volume":"9","author":"Y Xiao","year":"2024","unstructured":"Xiao, Y. et al. Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy. Signal Transduct. Target. Ther. 9, 272 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"70949_CR7","first-page":"S11","volume":"6","author":"C Clairmont","year":"1999","unstructured":"Clairmont, C. et al. Genetically modified Salmonella typhimurium, VNP20009, a novel anticancer agent:: bio-distribution, genetic stability, selective tumor accumulation, and antitumor efficacy. Cancer Gene Ther. 6, S11\u2013S12 (1999).","journal-title":"Cancer Gene Ther."},{"key":"70949_CR8","first-page":"3830S","volume":"5","author":"C Clairmont","year":"1999","unstructured":"Clairmont, C. et al. VNP20009, a genetically modified Salmonella typhimurium: anti-tumor efficacy, toxicology, and biodistribution in preclinical models. Clin. Cancer Res. 5, 3830S\u20133830S (1999).","journal-title":"Clin. Cancer Res."},{"key":"70949_CR9","first-page":"87","volume":"40","author":"KB Low","year":"1999","unstructured":"Low, K. B. et al. VNP20009, a genetically modified Salmonella typhimurium for treatment of solid tumors. Proc. Am. Assoc. Cancer Res. Annu. Meet. 40, 87\u201388 (1999).","journal-title":"Proc. Am. Assoc. Cancer Res. Annu. Meet."},{"key":"70949_CR10","doi-asserted-by":"publisher","unstructured":"Chang, Z. et al. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.02.002 (2025).","DOI":"10.1016\/j.cell.2025.02.002"},{"key":"70949_CR11","doi-asserted-by":"publisher","unstructured":"Roberts, N. J. et al. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.3008982 (2014).","DOI":"10.1126\/scitranslmed.3008982"},{"key":"70949_CR12","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.0406242101","volume":"101","author":"N Agrawal","year":"2004","unstructured":"Agrawal, N. et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc. Natl. Acad. Sci. USA 101, 15172\u201315177 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70949_CR13","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou, S., Gravekamp, C., Bermudes, D. & Liu, K. Tumour-targeting bacteria engineered to fight cancer. Nat. Rev. Cancer 18, 727\u2013743 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"70949_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/nbt1256","volume":"24","author":"C Bettegowda","year":"2006","unstructured":"Bettegowda, C. et al. The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT. Nat. Biotechnol. 24, 1573\u20131580 (2006).","journal-title":"Nat. Biotechnol."},{"key":"70949_CR15","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Dressing bacteria with a hybrid immunoactive nanosurface to elicit dual anticancer and antiviral immunity. Adv. Mater. https:\/\/doi.org\/10.1002\/adma.202210949 (2023).","DOI":"10.1002\/adma.202210949"},{"key":"70949_CR16","doi-asserted-by":"publisher","unstructured":"Li, J. J. et al. Decorating bacteria with triple immune nanoactivators generates tumor-resident living immunotherapeutics. Angew. Chem. Int. Ed. https:\/\/doi.org\/10.1002\/anie.202202409 (2022).","DOI":"10.1002\/anie.202202409"},{"key":"70949_CR17","doi-asserted-by":"publisher","first-page":"13832","DOI":"10.1073\/pnas.0406035101","volume":"101","author":"DG Brockstedt","year":"2004","unstructured":"Brockstedt, D. G. et al. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc. Natl. Acad. Sci. USA 101, 13832\u201313837 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70949_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/1078-0432.CCR-11-2121","volume":"18","author":"DT Le","year":"2012","unstructured":"Le, D. T. et al. A live-attenuated listeria vaccine (ANZ-100) and a live-attenuated listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin. Cancer Res. 18, 858\u2013868 (2012).","journal-title":"Clin. Cancer Res."},{"key":"70949_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1200\/JCO.2014.57.4244","volume":"33","author":"DT Le","year":"2015","unstructured":"Le, D. T. et al. Safety and survival With GVAX pancreas prime and listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J. Clin. Oncol. 33, 1325 (2015).","journal-title":"J. Clin. Oncol."},{"key":"70949_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142\u2013152 (2002).","journal-title":"J. Clin. Oncol."},{"key":"70949_CR21","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/1078-0432.CCR-04-2510","volume":"11","author":"DH Thamm","year":"2005","unstructured":"Thamm, D. H. et al. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia:: phase I evaluation. Clin. Cancer Res. 11, 4827\u20134834 (2005).","journal-title":"Clin. Cancer Res."},{"key":"70949_CR22","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/S0959-8049(16)32878-7","volume":"69","author":"F Janku","year":"2016","unstructured":"Janku, F. et al. Phase I clinical study of intratumoral injection of oncolytic Clostridium novyi-NT spores in patients with advanced cancers. Eur. J. Cancer 69, S94\u2013S94 (2016).","journal-title":"Eur. J. Cancer"},{"key":"70949_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318\u20131322 (1999).","journal-title":"Science"},{"key":"70949_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740\u2013745 (2000).","journal-title":"Nature"},{"key":"70949_CR25","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. In situ production and precise release of bioactive GM-CSF and siRNA by engineered bacteria for macrophage reprogramming in cancer immunotherapy. Biomaterials https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123037 (2025).","DOI":"10.1016\/j.biomaterials.2024.123037"},{"key":"70949_CR26","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.adj7621","volume":"383","author":"MFJ Mabesoone","year":"2024","unstructured":"Mabesoone, M. F. J. et al. Evolution-guided engineering of trans-acyltransferase polyketide synthases. Science 383, 1312\u20131317 (2024).","journal-title":"Science"},{"key":"70949_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-024-08417-6","volume":"638","author":"A Pistofidis","year":"2025","unstructured":"Pistofidis, A. et al. Structures and mechanism of condensation in non-ribosomal peptide synthesis. Nature 638, 270\u2013278 (2025).","journal-title":"Nature"},{"key":"70949_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"MS Jang","year":"1997","unstructured":"Jang, M. S. et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218\u2013220 (1997).","journal-title":"Science"},{"key":"70949_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur, J. A. & Sinclair, D. A. Therapeutic potential of resveratrol:: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493\u2013506 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70949_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Products 79, 629\u2013661 (2016).","journal-title":"J. Nat. Products"},{"key":"70949_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108150","volume":"65","author":"S Xu","year":"2023","unstructured":"Xu, S., Gao, S. & An, Y. Research progress of engineering microbial cell factories for pigment production. Biotechnol. Adv. 65, 108150 (2023).","journal-title":"Biotechnol. Adv."},{"key":"70949_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1365-2958.2005.04602.x","volume":"56","author":"NR Williamson","year":"2005","unstructured":"Williamson, N. R. et al. Biosynthesis of the red antibiotic, prodigiosin, in Serratia: identification of a novel 2-methyl-3-n-amyl-pyrrole (MAP) assembly pathway, definition of the terminal condensing enzyme, and implications for undecylprodigiosin biosynthesis in Streptomyces. Mol. Microbiol. 56, 971\u2013989 (2005).","journal-title":"Mol. Microbiol."},{"key":"70949_CR33","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1007\/s13197-014-1601-6","volume":"52","author":"HS Tuli","year":"2015","unstructured":"Tuli, H. S., Chaudhary, P., Beniwal, V. & Sharma, A. K. Microbial pigments as natural color sources: current trends and future perspectives. J. Food Sci. Technol. 52, 4669\u20134678 (2015).","journal-title":"J. Food Sci. Technol."},{"key":"70949_CR34","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1007\/s13197-015-1740-4","volume":"52","author":"N Darshan","year":"2015","unstructured":"Darshan, N. & Manonmani, H. K. Prodigiosin and its potential applications. J. Food Sci. Technol. 52, 5393\u20135407 (2015).","journal-title":"J. Food Sci. Technol."},{"key":"70949_CR35","doi-asserted-by":"publisher","first-page":"13150","DOI":"10.1073\/pnas.1616336113","volume":"113","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. Prodigiosin inhibits Wnt\/\u03b2-catenin signaling and exerts anticancer activity in breast cancer cells. Proc. Natl. Acad. Sci. USA 113, 13150\u201313155 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70949_CR36","doi-asserted-by":"publisher","unstructured":"Liu, S. et al. Preparation, characterization, formation mechanism, and stability studies of zein\/pectin nanoparticles for the delivery of prodigiosin. Int. J. Biol. Macromol. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138915 (2025).","DOI":"10.1016\/j.ijbiomac.2024.138915"},{"key":"70949_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.977337","volume":"13","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Improving prodigiosin production by transcription factor engineering and promoter engineering in Serratia marcescens. Front. Microbiol. 13, 977337 (2022).","journal-title":"Front. Microbiol."},{"key":"70949_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21307\/pjm-2019-005","volume":"68","author":"EG Romanowski","year":"2019","unstructured":"Romanowski, E. G. et al. Thermoregulation of prodigiosin biosynthesis by Serratia marcescens is controlled at the transcriptional level and requires HexS. Pol. J. Microbiol. 68, 43\u201350 (2019).","journal-title":"Pol. J. Microbiol."},{"key":"70949_CR39","doi-asserted-by":"publisher","first-page":"e57634","DOI":"10.1371\/journal.pone.0057634","volume":"8","author":"RM Shanks","year":"2013","unstructured":"Shanks, R. M. et al. A Serratia marcescens PigP homolog controls prodigiosin biosynthesis, swarming motility and hemolysis and is regulated by cAMP-CRP and HexS. PLoS ONE 8, e57634 (2013).","journal-title":"PLoS ONE"},{"key":"70949_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1128\/JB.00352-10","volume":"193","author":"T Gristwood","year":"2011","unstructured":"Gristwood, T., McNeil, M. B., Clulow, J. S., Salmond, G. P. & Fineran, P. C. PigS and PigP regulate prodigiosin biosynthesis in Serratia via differential control of divergent operons, which include predicted transporters of sulfur-containing molecules. J. Bacteriol. 193, 1076\u20131085 (2011).","journal-title":"J. Bacteriol."},{"key":"70949_CR41","doi-asserted-by":"publisher","unstructured":"Magiera-Mularz, K. et al. Macrocyclic peptide inhibitor of PD-1\/PD-L1 immune checkpoint. Adv. Therap. https:\/\/doi.org\/10.1002\/adtp.202000195 (2020).","DOI":"10.1002\/adtp.202000195"},{"key":"70949_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0076-6879(94)36030-8","volume":"236","author":"EA Elsinghorst","year":"1994","unstructured":"Elsinghorst, E. A. Measurement of invasion by gentamicin resistance. Methods Enzymol. 236, 405\u2013420 (1994).","journal-title":"Methods Enzymol."},{"key":"70949_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s43018-021-00221-9","volume":"2","author":"L Haas","year":"2021","unstructured":"Haas, L. et al. Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumour microenvironment and cross-resistance to immunotherapy in melanoma. Nat. Cancer 2, 693\u2013708 (2021).","journal-title":"Nat. Cancer"},{"key":"70949_CR44","first-page":"eabb5445","volume":"13","author":"PM Grierson","year":"2021","unstructured":"Grierson, P. M. et al. The MK2\/Hsp27 axis is a major survival mechanism for pancreatic ductal adenocarcinoma under genotoxic stress. Sci. Transl. Med. 13, eabb5445 (2021).","journal-title":"Sci. Transl. Med."},{"key":"70949_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abc1044","volume":"14","author":"CC Rada","year":"2021","unstructured":"Rada, C. C. et al. Heat shock protein 27 activity is linked to endothelial barrier recovery after proinflammatory GPCR-induced disruption. Sci. Signal 14, eabc1044 (2021).","journal-title":"Sci. Signal"},{"key":"70949_CR46","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot, D., Latz, E. & Franklin, B. S. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell. Mol. Immunol. 18, 1106\u20131121 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"70949_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2023","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379\u2013395 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70949_CR48","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1039\/D0CS00664E","volume":"50","author":"C Xu","year":"2021","unstructured":"Xu, C. & Pu, K. Second near-infrared photothermal materials for combinational nanotheranostics. Chem. Soc. Rev. 50, 1111\u20131137 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"70949_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305645","volume":"20","author":"N Li","year":"2024","unstructured":"Li, N., Wang, Y., Li, Y., Zhang, C. & Fang, G. Recent advances in photothermal therapy at near-infrared-II based on 2D MXenes. Small 20, e2305645 (2024).","journal-title":"Small"},{"key":"70949_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2022.03.010","volume":"345","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. A triple enhanced permeable gold nanoraspberry designed for positive feedback interventional therapy. J. Control Release 345, 120\u2013137 (2022).","journal-title":"J. Control Release"},{"key":"70949_CR51","doi-asserted-by":"publisher","unstructured":"Hu, D., Zha, M., Zheng, H., Gao, D. & Sheng, Z. Recent advances in indocyanine green-based probes for second near-infrared fluorescence imaging and therapy. Research https:\/\/doi.org\/10.34133\/research.0583 (2025).","DOI":"10.34133\/research.0583"},{"key":"70949_CR52","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00253-021-11149-6","volume":"105","author":"L Ji","year":"2021","unstructured":"Ji, L. et al. Enhancing L-malate production of Aspergillus oryzae by nitrogen regulation strategy. Appl. Microbiol. Biotechnol. 105, 3101\u20133113 (2021).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"70949_CR53","doi-asserted-by":"publisher","unstructured":"Xiang, T. et al. Transcriptomic analysis reveals competitive growth advantage of non-pigmented Serratia marcescens mutants. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.793202 (2022).","DOI":"10.3389\/fmicb.2021.793202"},{"key":"70949_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-01744-0","volume":"9","author":"Q He","year":"2024","unstructured":"He, Q. et al. A novel alternative for pyrogen detection based on a transgenic cell line. Signal Transduct. Target Ther. 9, 33 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"70949_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47947-5","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Biocompatible aggregation-induced emission active polyphosphate-manganese nanosheets with glutamine synthetase-like activity in excitotoxic nerve cells. Nat. Commun. 15, 3534 (2024).","journal-title":"Nat. Commun."},{"key":"70949_CR56","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-21-0094","volume":"9","author":"C Guenther","year":"2021","unstructured":"Guenther, C. et al. \u03b22-integrin adhesion regulates dendritic cell epigenetic and transcriptional landscapes to restrict dendritic cell maturation and tumor rejection. Cancer Immunol. Res. 9, 1354\u20131369 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"70949_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50950-5","volume":"15","author":"DH Nguyen","year":"2024","unstructured":"Nguyen, D. H. et al. Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella. Nat. Commun. 15, 6680 (2024).","journal-title":"Nat. Commun."},{"key":"70949_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202400829","volume":"63","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. A ferroptosis-inducing arsenene-iridium nanoplatform for synergistic immunotherapy in pancreatic cancer. Angew. Chem. Int. Ed. Engl. 63, e202400829 (2024).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"70949_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202203200","volume":"18","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Hierarchical assembly of flexible biopolymer polyphosphate-manganese into nanosheets. Small 18, e2203200 (2022).","journal-title":"Small"},{"key":"70949_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/ot9.0000000000000063","volume":"10","author":"S Chen","year":"2024","unstructured":"Chen, S., Li, S. & Wang, H. Remodeling tumor-associated macrophages in the tumor microenvironment. Oncol. Transl. Med. 10, 281\u2013285 (2024).","journal-title":"Oncol. Transl. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70949-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70949-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70949-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:02:16Z","timestamp":1780534936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70949-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70949"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70949-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4956"}}